Novartis AG logo

Novartis AG Investor Relations Material

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. It operates through three segments: Pharmaceuticals, Alcon, and Sandoz. The company offers patented prescription drugs for cancers; cardiovascular and gastrointestinal diseases; central nervous system disorders; inflammatory ailments; and organ transplantation. The company also provides patented over-the-counter medications to treat coughs and colds; pain management; skin care; eye care; oral care; digestive health products; oral nutritionals, such as infant formulas and nutritional beverages for the elderly population based on science-based formulations using specialized processing technologies; topical antifungal treatment creams that treat athlete's foot, jock itch, ringworm, and other fungal infections of the skin, scalp or nails; smoking cessation aids under the Nicorette name in Europe and Australia/New Zealand

Upcoming events for

Q3 20222022-10-25
Q2 20222022-07-19

Latest company events

Ticker symbol

NOVN

Country

Switzerland

About the company

https://www.novartis.com/

Investor Relations Page

https://www.novartis.com/investors

Dig deeper into the Novartis AG fundamentals on Quartr.

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
App store link
Android play link
Quartr app screenshot